NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulato...(date of this press release and involve c...),Health

Date:7/6/2009

date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2008 and the Company's other periodic filings with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

            CONTACT:
            NeoStem, Inc.
            Robin Smith, Chief Executive Officer
            T: 212-584-4180
            E: rsmith@neostem.com

'/>"/>

SOURCE NeoStem, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. NeoStem, Inc. Comments on Recent Selling Pressure
2. Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry
3. Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years
4. Celleration Appoints Mark T. Wagner President and Chief Executive Officer
5. XLHealth Appoints New Vice President of Contracting and Provider Relations
6. Wisconsin Tobacco Tax Increase Is Positive Step for Health, but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs
7. Verathon Inc. Appoints Kendall Stever as Chief Financial Officer
8. Tyco Electronics Appoints Cuong Do as Senior Vice President, Corporate Strategy & Business Development
9. Symmetry Medical Appoints Chairman and Two Directors
10. GBS/CIDP Foundation International Appoints Patricia A. Bryant as Executive Director
11. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy